GRI Bio (NASDAQ: GRI) to Participate in the Virtual Investor Lunch Break Series

LA JOLLA, CA, July 15, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) ("GRI Bio," "we," "our," or the "Company"), a biotechnology company advancing an innovative pipeline of Natural Killer T (NKT) cell modulators for the treatment of inflammatory, fibrotic and autoimmune diseases, today announced that it will participate in the Virtual Investor Lunch Break Series on July 17, 2024 at 12:00 PM ET. About GRI Bio, Inc. Live video webcast on Wednesday, July 17th at 12:00 PM ET A live video webcast of the p ...